Production (Stage)
Burcon Nutrascience Corporation
BU.TO
TSX
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -23.38% | 26.19% | -26.39% | 10.99% | -2.80% |
Total Depreciation and Amortization | 166.28% | -6.86% | 11.69% | -41.44% | 126.47% |
Total Amortization of Deferred Charges | -2.52% | -2.59% | 0.39% | -1.53% | 0.90% |
Total Other Non-Cash Items | 24.33% | 41.58% | 17.50% | 4.47% | -26.90% |
Change in Net Operating Assets | 179.85% | -154.83% | 242.19% | -226.23% | -1,468.49% |
Cash from Operations | 31.80% | -18.84% | 35.08% | -6.66% | -16.35% |
Capital Expenditure | -516.16% | 50.25% | 84.43% | -579.79% | 54.81% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -25,857.89% | -64.15% | -50.70% | 65.38% | 25.00% |
Cash from Investing | -17,231.67% | 35.48% | 91.25% | -1,732.76% | 81.41% |
Total Debt Issued | -78.50% | -- | -- | -- | -- |
Total Debt Repaid | -3,801.79% | 47.66% | 75.51% | 47.98% | -813.04% |
Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -2,712.20% | 200.00% | 62.56% | 64.62% | -- |
Cash from Financing | 794.28% | 927.69% | 245.51% | -101.24% | 57,019.12% |
Foreign Exchange rate Adjustments | -85.96% | 208.57% | -166.88% | 36.52% | 169.28% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 1,561.99% | 61.40% | 44.48% | -156.91% | 328.94% |